Immunovia

In News

Equity research Immunovia Q1 2026: Initial commercialisation phase on track - Carlsquare Corporate Finance

Carlsquare Corporate Finance - May 11, 2026

Equity research Immunovia, Q3 2025: US reimbursement in focus - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 27, 2025

Immunovia publishes the Annual Report for 2025 - Finansavisen

Finansavisen - Apr 10, 2026

Immunovia’s next-gen pancreatic cancer test shows strong performance in validation study - Medical Economics

Medical Economics - Mar 19, 2025

Immunovia Q2 2025 slides: PancreaSure launch plan unveiled amid stock decline - Investing.com

Investing.com - Aug 28, 2025

Next-Generation Test Shows Sensitivity/Specificity in Pancreatic Cancer - CancerNetwork

CancerNetwork - Mar 26, 2025

Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress - Carlsquare Corporate Finance

Carlsquare Corporate Finance - Nov 26, 2025

Pancreatic Cystic Neoplasm Study to Include Immunovia NGS Test - Clinical Lab Products

Clinical Lab Products - Aug 06, 2024

Immunovia invites to a presentation on the Q1 report and 2026 objectives - Finansavisen

Finansavisen - May 04, 2026

Immunovia AB Stock (IMMNOV) - Quote Nasdaq Stockholm - marketscreener.com

marketscreener.com - Jan 24, 2024

Immunovia Publishes Interim Report for January-June 2024 - Cision News

Cision News - Aug 05, 2024

Immunovia Gets California Lab License for Pancreatic Cancer Test - GenomeWeb

GenomeWeb - Aug 11, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment